Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells

Mediators of Inflammation

Volumn 2006, Issue , 2006, Pages

  Chrul, Slawomir ^a   Polakowska, Ewa ^a   Szadkowska, Agnieszka ^a   Bodalski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD36 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; GLYCOPHORIN A; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; KIR RECEPTORS; KIR2DL1 PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL SURFACE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; METHODOLOGY; PRESCHOOL CHILD;

CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE; RECEPTORS, IMMUNOLOGIC;

EID: 33746844918     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI/2006/46957     Document Type: Article

References (47)

1. A R French W M Yokoyama yokoyama@imgate.wustl.edu Natural killer cells and viral infections. Current Opinion in Immunology 15 2003 1 45 51 12495732
2. J B VanDeusen M A Caligiuri caligiuri-1@medctr.osu.edu New developments in anti-tumor efficacy and malignant transformation of human natural killer cells. Current Opinion in Hematology 10 1 2003 55 59
3. A G Baxter M J Smyth The role of NK cells in autoimmune disease. Autoimmunity 35 1 2002 1 14
4. G Trinchieri Biology of natural killer cells. Advances in Immunology 47 1989 187 376
5. R B Herberman J R Ortaldo Natural killer cells: their role in defenses against disease. Science 214 4516 1981 24 30
6. C A Biron Christine_Biron@brown.edu K B Nguyen G C Pien L P Cousens T P Salazar-Mather Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annual Review of Immunology 17 1999 189 220
7. A A Maghazachi azzam.maghazachi@basalmed.uio.no Chemokines, G proteins and natural killer cells. Archivum Immunologiae et Therapiae Experimentalis 48 2000 2 65 72 10807045
8. A M Martin E M Freitas C S Witt F T Christiansen ftchrist@cyllene.uwa. edu.au The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics 51 2000 4-5 268 280 10803839
9. U Steffens Y Vyas B Dupont A Selvakumar Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998. Tissue Antigens 51 1998 4 pt 1 398 413 9583814
10. H G Shilling L A Guethlein N W Cheng Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. Journal of Immunology 168 5 2002 2307 2315
11. D Pende R Biassoni C Cantoni The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide- linked dimer. Journal of Experimental Medicine 184 2 1996 505 518
12. P Hansasuta T Dong H Thananchai Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. European Journal of Immunology 34 6 2004 1673 1679
13. M Toneva V Lepage G Lafay Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 57 4 2001 358 362
14. M A Cook mark.cook@nbs.nhs.uk P AH Moss D C Briggs The distribution of 13 killer-cell immunoglobulin-like receptor loci in UK blood donors from three ethnic groups. European Journal of Immunogenetics 30 3 2003 213 221
15. O Mandelboim S Kent D M Davis Natural killer activating receptors trigger interferon γ secretion from T cells and natural killer cells. Proceedings of the National Academy of Sciences of the United States of America 95 7 1998 3798 3803
16. M H Johansson C Bieberich G Jay K Kärre P Höglund Petter.Hoglund@mtc.ki.se Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. Journal of Experimental Medicine 186 3 1997 353 364
17. S KP Kung R G Miller Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo. Journal of Immunology 158 6 1997 2616 2626
18. M Salcedo M Andersson S Lemieux L Van Kaer B J Chambers H Ljunggren hanlju@ki.se Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. European Journal of Immunology 28 4 1998 1315 1321
19. W E Carson J G Giri M J Lindemann Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. Journal of Experimental Medicine 180 4 1994 1395 1403
20. L L Lanier D W Buck L Rhodes Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. Journal of Experimental Medicine 167 5 1988 1572 1585
21. H Okamura H Tsutsui T Komatsu Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378 6552 1995 88 91
22. Y Hyodo K Matsui N Hayashi IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. Journal of Immunology 162 3 1999 1662 1668
23. D L Hodge W B Schill J M Wang IL-2 and IL-12 alter NK cell responsiveness to IFN-γ-inducible protein 10 by down-regulating CXCR3 expression. Journal of Immunology 168 12 2002 6090 6098
24. B R Lauwerys N Garot J C Renauld F A Houssiau Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. Journal of Immunology 165 4 2000 1847 1853
25. T Fukao S Matsuda S Koyasu koyasu@sun.microb.med.keio.ac.jp Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-γ production by dendritic cells. Journal of Immunology 164 1 2000 64 71
26. C L Hofstra C.L.Hofstra@Pharm.UU.NL I Van Ark G Hofman M Kool F P Nijkamp A JM Van Oosterhout Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. Journal of Immunology 161 9 1998 5054 5060
27. B R Lauwerys J C Renauld F A Houssiau houssiau@ruma.ucl.ac.be Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine 11 11 1999 822 830
28. M Tomura X Y Zhou S Maruo A critical role for IL-18 in the proliferation and activation of NK 1.1+ CD 3- cells. Journal of Immunology 160 10 1998 4738 4746
29. K Yamanaka I Hara H Nagai Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model. Cancer Immunology Immunotherapy 48 6 1999 297 302
30. E Aktas M Akdis S Bilgic Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clinical and Experimental Immunology 140 2 2005 301 309
31. M Draghi N Yawata M Gleimer M Yawata N M Valiante P Parham peropa@stanford.edu Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I. Blood 105 5 2005 2028 2035
32. G Ferlazzo ferlazg@mail.rockefeller.edu D Thomas S L Lin The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. Journal of Immunology 172 3 2004 1455 1462
33. R Gazit B Z Garty Y Monselise Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103 5 2004 1965 1966
34. T Momot S Koch N Hunzelmann Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis and Rheumatism 50 5 2004 1561 1565
35. P Musette L Michel F Jean-Louis M Bagot A Bensussan Polymorphic expression of CD158k/p140/KIR3DL2 in Sézary patients. Blood 101 3 2003 1203
36. P K Epling-Burnette burnetpk@moffitt.usf.edu J S Painter P Chaurasia Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 103 9 2004 3431 3439
37. R Miyashita N Tsuchiya tsuchiya-tky@umin.ac.jp T Yabe Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. Arthritis and Rheumatism 54 3 2006 992 997
38. G Batoni batoni@biomed.unipi.it S Esin F Favilli Human CD 56 bright and CD 56 dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Scandinavian Journal of Immunology 62 6 2005 498 506
39. Y Jin B B Damaj A A Maghazachi Human resting CD 16-, CD 16+ and IL-2-, IL-12-, IL-15- or IFN-α-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. European Journal of Immunology 35 9 2005 2699 2708
40. M Vitale M Della Chiesa S Carlomagno NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor. Blood 106 2 2005 566 571
41. E Marcenaro B Ferranti A Moretta alemoret@unige.it NK-DC interaction: on the usefulness of auto-aggression. Autoimmunity Reviews 4 8 2005 520 525
42. E C Shin K S Choi S J Kim J S Shin jsshin6203@yumc.yonsei.ac.kr Modulation of the surface expression of CD158 killer cell Ig-like receptor by interleukin-2 and transforming growth factor-β Yonsei Medical Journal 45 3 2004 510 514
43. T Kogure kogu2737@ms.toyama-mpu.ac.jp H Fujinaga A Niizawa Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-γ or interleukin-4. Mediators of Inflammation 8 6 1999 313 318
44. K Matsumoto K Kanmatsuse Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome. Nephron 85 2 2000 127 133
45. M Nakahira H J Ahn W R Park Synergy of IL-12 and IL-18 for IFN-γ gene expression: IL-12-induced STAT4 contributes to IFN-γ promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1-. Journal of Immunology 168 3 2002 1146 1153
46. M Okamoto S Kato K Oizumi Interleukin 18 (Il-18) in synergy with Il-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia. Blood 99 4 2002 1289 1298
47. M Tarkowski S Chrul J Bodalski The effect of IL-18 on IL-12-induced CD30 expression and IL-4 and IFN-γ production by allergen and PPD specific T cells. Clinical and Experimental Immunology 127 1 2002 78 84